GPS: Clínica Médica

Fernanda Mazza · Capítulo 38 de 96

Páginas do PDF

GPS: Clínica Médica

Bibliografia Sugerida

Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica (Abeso); Diretrizes brasileiras de obesidade. São

Paulo: AC Farmacêutica, 2009.

Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica (Abeso) e Sociedade Brasileira de Endocrinologia e

Metabologia. Atualização das diretrizes para o tratamento Farmacológico da obesidade e do sobrepeso. São Paulo: AC

Farmacêutica, 2010.

Barkan A, Bronstein MD, Bruno OD, Cob A, Espinosa-de-los-Monteros AL, Gadelha MR et al. Management of acromegaly in Latin

America: expert panel recommendations. Pituitary. 2010; 13(2):168-75.

Benchimol AK, Moraes A, Bittar T. Indicações e contraindicações da cirurgia bariátrica. In: Avaliação clínica pré e pós-operatória na

cirurgia bariátrica. Rio de Janeiro: AC Farmacêutica, 2009. p. 11-5.

Benchimol AK, Moraes A, Bittar T. Opções cirúrgicas no tratamento da obesidade. In: Avaliação clínica pré e pós-operatória na

cirurgia bariátrica. Rio de Janeiro: AC Farmacêutica, 2009. p. 24-34.

Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician. 2006; 73(10):1769-76.

Boguszewski CL. O laboratório no diagnóstico e seguimento da acromegalia. Arq Bras Endocrinol Metab. 2002; 46(1):34-44.

Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA. Insulin analogues and their potential in the management of diabetes

mellitus. Diabetologia. 1999 Oct; 42(10):1151-67.

Bolli GB. Insulin treatment in type 1 diabetes. Endocr Pract. 2006; 12(Suppl 1):105-9.

Carlsson LMS et al. Bariatric surgery and prevention of type 2 diabetes in swedish obese subjects. N Engl J Med. 2012; 367:695-

704.

Cotta-Pereira R, Cotta-Pereira G, Benchimol AK. Tratamento cirúrgico da obesidade. In: Guedes EP, Moreira RO, Benchimol AK.

Endocrinologia. Rio de Janeiro: Editora Rubio, 2006. p. 29-43.

Coutinho WF. Abordagem clínica da obesidade. In: Guedes EP, Moreira RO, Benchimol AK. Endocrinologia. Rio de Janeiro: Editora

Rubio, 2006. p. 25-8.

Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL. Acromegaly with apparently normal GH secretion: Implications

for diagnosis and follow-up. J Clin Endocrinol Metab. 2002; 87(8):3537-42.

Sociedade Brasileira de Diabetes (SBD). Diretrizes da Sociedade Brasileira de Diabetes. Alvos no controle clínico e metabólico de

crianças e adolescentes com diabetes mellitus tipo 1. 2011. p. 80-3.

Diretrizes da Sociedade Brasileira de Diabetes. Avaliação do controle glicêmico. Disponível em: <http://www.diabetes.org.br>.

Acesso em: 9 jan 2013.

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term

follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999; 22(1):99-111.

Faria AM, Mancini MC, Melo ME, Cercato C, Halpern A. Progressos recentes e novas perspectivas em farmacoterapia da obesidade.

Arq Bras Endocrinol Metab. 2010; 54:6.

Flint HJ. Obesity and the gut microbiota. J Clin Gastroenterology. 2011; 45(supp3):129-32.

Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al. Criteria for cure of acromegaly: A consensus statement. J

Clin Endocrinol Metab. 2000; 85(2):526-9.

Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al. A Consensus on Criteria for Cure of Acromegaly. J

Clin Endocrinol Metab. 2010; 95(7):3141-8.

Guyenet SJ, Schwartz MW. Regulation of food intake, energy balance, and body fat mass: Implications for the pathogenesis and

treatment of obesity. J Clin Endocrinol Metab. 2012 Mar; 97(3):745-55.

Bahn Chair RS, Burch HB, Cooper DS et al. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the

American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011; 21(6):593-646.

Jacobs DO. Bariatric Surgery - From treatment of disease to prevention? N Engl J Med. 2012; 367: 764-65.

Koote RS et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes, Obesity

and Metabolism. 2012; 14:112-20.

Lamounier RN, Minicucci W. Tratamento do diabetes tipo 1. In: Lamounier RN et al. Manual prático de diabetes: prevenção,

detecção e tratamento. 4. ed. São Paulo: AC Farmacêutica, 2011.

Larsen PR, Davies TF. Hypothyroidism and Thyroiditis. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Williams Textbook of

Endocrinology. 10. ed. Philadelphia: W.B. Saunders Company, 2003. p. 423-45.

Ludvigsson J, Bolli GB. Intensive insulin treatment in diabetic children. Diabetes Nutr Metab. 2001; 14(5):292-304.

Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D et al. Guidelines for acromegaly management: an update. J

Clin Endocrinol Metab. 2009; 94(5):1509-17.

Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ. Assessment and monitoring of glycemic control in children

and adolescents with diabetes. Pediatr Diabetes. 2007; 8(6):408-18.

Rodgers J, Tschöp MH, Wilding JPH. Anti-obesity drugs: Past, present and future. Disease Models & Mechanisms. 2012; 5:621-6.

Samuels MH. Subacute, silente and postpartum thyroiditis. Med Clin North Am. 2012; 96(2):223-33.

Slatosky J, Shipton B, Wahba H. Thyroiditis: Differential diagnosis and management. Am Fam Physician. 2000; 61(4):1047-52,

1054.

American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care. 2010 Jan; 33(Suppl 1):S11-61.

[No authors listed]. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on

the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993

Sep 30; 329(14):977-86.

Tschidel B, Puñales M. Esquema de insulinização no diabetes tipo 1. In: Diabetes na prática clínica. Disponível em:

<http://www.diabetesebook.org.br>. Acesso em: 9 jan 2013.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with

conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;

352(9131):837-53.

Vieira Neto L, Abucham J, Araujo LA, Boguszewski CL, Bronstein MD, Czepielewski M et al. Recommendations of

Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of

acromegaly in Brazil. Arq Bras Endocrinol Metabol. 2011; 55(2):91-105.

White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV. Bene cial effects of intensive therapy of diabetes during

adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr. 2001;

139(6):804-12.

OceanofPDF.com